Teva confirms efficacy in late-stage trial of its migraine treatment for adult Chinese patients
https://seekingalpha.com/news/4088897-teva-confirms-efficacy-in-late-stage-trial-of-its-migraine-treatment-for-adult-chinese-patients?source=feed_tag_israel
Apr 11, 2024 - Late-stage study confirms efficacy and safety of Teva Pharmaceutical's AJOVY in preventing migraines in adult Chinese patients.
0
Teva: Sustained Revenue Growth Amid Financial Strain (Rating Downgrade)
https://seekingalpha.com/article/4691152-teva-sustained-revenue-growth-amid-financial-strain-rating-downgrade?source=feed_tag_israel
May 08, 2024 - Teva's blockbuster drugs continue to show robust growth and contribute to the company's revenue. See why TEVA stock is a Hold.
0
Teva wins FDA nod for new Austedo formulation
https://seekingalpha.com/news/4111457-teva-wins-fda-nod-new-austedo-version?source=feed_tag_israel
May 30, 2024 - Teva Pharmaceutical (TEVA) has gained FDA approval to market Austedo XR in four new dosing strengths in the U.S. Read more here.
0
Teva Pharmaceutical Industries Limited (TEVA) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)
https://seekingalpha.com/article/4698647-teva-pharmaceutical-industries-limited-teva-goldman-sachs-45th-annual-global-healthcare?source=feed_tag_israel
Jun 11, 2024 - Teva Pharmaceutical Industries Limited (NYSE:NYSE:TEVA) Goldman Sachs 45th Annual Global Healthcare Conference Call June 11, 2024 8:00 AM ETCompany...
0
Teva asthma inhaler patents are 'improperly listed' in FDA Orange Book
https://seekingalpha.com/news/4115251-teva-asthma-inhaler-patents-are-improperly-listed-in-fda-orange-book?source=feed_tag_israel
Jun 12, 2024 - A New Jersey judge ruled that Teva's patents for its ProAir HFA inhaler were listed improperly in the FDA's Orange Book, benefiting Amneal Pharmaceuticals.
0
Teva focus of FTC investigation over inhaler patents
https://seekingalpha.com/news/4121149-teva-focus-ftc-investigation-inhaler-patents?source=feed_tag_israel
Jul 01, 2024 - The FTC has launched an investigation into Teva Pharmaceutical's refusal to withdraw patents allegedly delaying generic competition for asthma and COPD inhalers. read more here.
0
Teva's Q2 Outlook: Key Developments In Biosimilars And Pipeline Drugs
https://seekingalpha.com/article/4707032-teva-q2-earnings-preview-key-developments-biosimilars-pipeline-drugs?source=feed_tag_israel
Jul 26, 2024 - Teva Pharmaceutical stock is up 69% since December. The company is set for Q2 earnings on July 31. See why I maintain my Hold rating on TEVA stock.
0
Teva Pharmaceutical Q2 2024 Earnings Preview
https://seekingalpha.com/news/4130294-teva-pharmaceutical-q2-2024-earnings-preview?source=feed_tag_israel
Jul 30, 2024 - Teva Pharmaceutical (TEVA) is set to announce Q2 earnings on July 31st.
0
Teva gains after lifting outlook on YTD performance
https://seekingalpha.com/news/4130982-teva-stock-gains-revised-outlook?source=feed_tag_israel
Jul 31, 2024 - Teva Pharmaceutical (TEVA) stock gained after the reported strong Q2 2024 financials, raising its full-year outlook. Read more here.
0
Teva Pharmaceutical Industries Limited 2024 Q2 - Results - Earnings Call Presentation
https://seekingalpha.com/article/4708478-teva-pharmaceutical-industries-limited-2024-q2-results-earnings-call-presentation?source=feed_tag_israel
Jul 31, 2024 - The following slide deck was published by Teva Pharmaceutical Industries Limited in conjunction with their 2024 Q2 earnings call.
0